Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Gan To Kagaku Ryoho ; 36(13): 2653-5, 2009 Dec.
Artículo en Japonés | MEDLINE | ID: mdl-20009474

RESUMEN

A 33-year-old man was admitted to our hospital due to DIC and multiple bone metastasis after distal gastrectomy for gastric cancer (Stage IIIB). We diagnosed disseminated carcinomatosis of bone marrow by gastric cancer. The patient was treated with combination chemotherapy of S-1 and CDDP (S-1 80 mg/m (2), po, day 1-21 and CDDP 60 mg/m(2), iv, day 8). After one course of the treatment, DIC was resolved and severe pain in his back and legs which had been poorly controlled was dramatically improved. He could thus be discharged from our hospital and survived for about six months. S-1 and CDDP therapy are considered to be effective for disseminated carcinomatosis of bone marrow due to gastric cancer, even if complicated by DIC.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias Óseas/tratamiento farmacológico , Neoplasias Óseas/secundario , Carcinoma/tratamiento farmacológico , Carcinoma/secundario , Neoplasias Gástricas/patología , Adulto , Antimetabolitos Antineoplásicos/administración & dosificación , Cisplatino/administración & dosificación , Combinación de Medicamentos , Humanos , Masculino , Ácido Oxónico/administración & dosificación , Calidad de Vida , Tegafur/administración & dosificación
3.
Intern Med ; 41(7): 555-60, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12132524

RESUMEN

A 21-year-old woman was admitted with altered consciousness and hyperammonemia. She was diagnosed as having adult-onset type II citrullinemia (CTLN2) by DNA analysis. The patient had mutations of the SLC25A13 gene, which were compound heterozygotes of 851 del 4 and IVS11+1G>A. CTLN2 has a poor prognosis, in spite of various intensive medications, and we performed a living related partial liver transplantation (LRLT). Over a 2-year follow-up, the patient has been well. CTLN2 can be diagnosed by the DNA analysis and can be treated by LRLT.


Asunto(s)
Citrulinemia/diagnóstico , Citrulinemia/cirugía , Trastornos de la Conciencia/complicaciones , ADN/análisis , Trasplante de Hígado/métodos , Donadores Vivos , Adulto , Citrulinemia/complicaciones , Citrulinemia/genética , ADN/genética , Análisis Mutacional de ADN/métodos , Femenino , Humanos , Hiperamonemia/complicaciones , Mutación/genética , Recuperación de la Función , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA